Vitamin D Testing Market Forecasts to 2028 - Global Analysis By Product, Indication, Patient, Application, and By Geography

According to Stratistics MRC, the Global Vitamin D Testing Market is accounted for $584.66 million in 2021 and is expected to reach $932.71 million by 2028 growing at a CAGR of 6.9% during the forecast period. Vitamin D is a naturally present fat-soluble vitamin that is chemically related to steroids and assistance in the absorption of nutrients, phosphate, zinc, magnesium, and other minerals. Vitamin D regulates calcium phosphate balance in the bloodstream, which helps to maintain skeletal and tooth mineralization. In terms of improving immune function, it maintains the cell cycle, reduces the chances of bone deformity, and helps relieve joint surfaces. Vitamin D testing is used to evaluate for or monitor bone disorders. It has sometimes been used to check vitamin D levels in individuals with chronic illnesses such as asthma, psoriasis, and certain autoimmune diseases.

Market Dynamics:

Driver:

Increasing prevalence of vitamin D deficiency and associated diseases

The rising prevalence of vitamin D deficiency and associated diseases, including Inflammatory Bowel Disease (IBD) and osteoporosis are some of the major factors ensuing in the growing demand for this process. For example, according to an article published by WebMD LLC in April 2020, it was reported that the global prevalence of IBD is 396 cases per 100,000 persons annually. Moreover, this vast patient population suffering from vitamin D deficiency is seeking medical attention for the treatment and which results in economic burden. Ultimately, this led to augmented initiatives for a number of consciousness campaigns concerning the significance of vitamin D by the government and other for-profit and non-profit organizations. For instance, in 2021, Royal DSM launched a digital-led campaign in India with the goal of raising awareness about the importance of increasing vitamin D levels through good nutrition. This is responsible for the growing adoption of routine vitamin D testing and fueling the market growth during the study period.

Restraint:

Increasing initiatives to limit the overuse of Vitamin D testing

Vitamin D deficiency is one of the most vital factors related to the overall situation of health of a person. Though, a marked increase was experiential in repetitive testing in the developed economies, including the U.S., Germany, and others. This is resulting in the overuse of healthcare resources, such as reagents, test kits, and others, and consequently increases the healthcare burdens over period of time. Hence, a number of countries implemented certain regulatory guidelines regarding the vitamin testing frequency and usage of test kits. This considerably decreased the overutilization of healthcare resources as well as expenses and subsequently hindered the market growth during the study period. For instance, a decrease of around 23.3% in vitamin D tests was observed after providing a multi-level intervention program based on training, monitoring, and feedback on 23 primary care health centers in the Netherlands. Furthermore, the high cost associated with the test is also hindering the adoption of vitamin D tests among the general population in the emerging countries, including Brazil, South Africa, and others.

Opportunity:

Collaboration with government agencies for diagnosis of deficiency

The bulky numeral of patients anguish from vitamin D deficiency internationally is anticipated to augment the lucrativeness of the market of vitamin D. Likewise, the diagnostic laboratories can capitalize on this opportunity to enter a long-term contract for population-based studies. In addition, the manufacturers of diverse kits and assays can collaborate with research institutes to expand new products. Furthermore, the supply of kits, reagents, and equipment essential for vitamin D testing at an affordable price in developing regions can be a favourable strategy for players focused on geographic development.

Threat:

Unfavourable reimbursement scenario deterring adherence to testing

The high incidence of vitamin D insufficiency is accountable for the burden of allied diseases such as osteomalacia and rickets. A large number of patients are globally suffering from diseases related to bone health, metabolism, and chronic kidney diseases. The diagnosis of such diseases desires timely assessment of vitamin D levels. On the contrary, the reimbursement scenario is not favourable to address the bulky number of patients anguish from diverse associated conditions. The CPT Codes 82306 and 82652 for vitamin D testing are obtainable for reimbursement in the US. Though, in developing regions where a large population is pretentious by low levels of vitamin D, healthcare spending is not sufficient to address reimbursement concerns.

The 25-hydroxy vitamin D testing segment is expected to be the largest during the forecast period

The 25-hydroxy vitamin D testing segment is estimated to have a lucrative growth, due to its larger utility to assess body stores of vitamin D globally, availability of several commercial testing products, the ability of the test to detect bone malfunctions accurately, recent commercialization. In addition, the increasing incidence of vitamin D deficiency and insufficiency is surging the demand for this testing around the globe and consequently supporting the segmental dominance of this segment. Also, diversified application of 25- hydroxy vitamin D for the nutritional assessment has been instrumental in the growth of this segment. This is the most preferred testing option among medical practitioners, due to ease in testing through blood samples. For instance, in January 2015, Beckman Coulter Diagnostics received 510(k) clearance from the U.S.FDA for Access 25(OH) Vitamin D Total assay.

The hospitals & physician clinics segment is expected to have the highest CAGR during the forecast period

The hospitals & physician clinics segment is anticipated to witness the fastest CAGR growth during the forecast period owing to testing kits in hospital premises, availability of diagnostic health services, and growing initiatives for the expansion of hospital infrastructure. Hospitals and physician clinics are prime centers for addressing anomalous health conditions and receiving treatment. In addition, orthopedic hospitals require vitamin D levels tested for understanding the normal working of bones. Likewise, nutritionists need a complete profile of nutrients to advise and consult patients regarding diet.

Europe with highest share:

Europe is projected to hold the largest market share during the forecast period owing to rising R&D expenditure by government institutes, large elderly population, increasing number of clinical trials, and easy availability of products for vitamin D testing. Moreover, the increasing geriatric population suffering from orthopedic disorders drives the growth of the market in the region. Germany, France, and Italy are the key markets in Europe, and Spain, UK, and Switzerland are the emerging countries in this region, due to easy availability of products, good healthcare infrastructure, high healthcare expenditure, and local presence of major players. Approval of a large number of point of care testing products by the regulatory authority of this region, along with the increasing prevalence of vitamin D deficiency, is fueling the demand and adoption of the products in this region. For instance, according to an article published by the National Library of Medicine in 2019, it was reported that around 30.0-60.0% of the people in western, southern and eastern Europe were suffering from vitamin D deficiency.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to favourable reimbursement scenarios, availability of health screening tests, commercialization of innovative techniques, increasing geriatric population, growing awareness about the benefits of these tests, rapid urbanization, and healthcare expenditure in developing countries, including India, China, and Japan. Research institutes and NGOs collaborating for awareness and advancement of vitamin D status in the region are expected to increase the diagnosis rate through vitamin D testing. In July 2016, DiaSorin launched its CLIA 25 OH Vitamin D test in Japan after receiving approval of the reimbursement code from the Japanese authorities. Japan has about 13 million patients suffering from osteoporosis who will benefit from the test.

Key players in the market

Some of the key players profiled in the Vitamin D Testing Market include Abbott Laboratories, Siemens AG, Beckman Coulter, bioMerieux SA, Thermo Fisher Scientific, Bio-Rad Laboratories, DiaSorin S.p.A., F. Hoffmann-La Roche AG, Biokit S.A., Merck KGaA, Zhejiang Xinhecheng Co., Ltd., Fermenta Biotech Limited, Danaher Corporation, Diazyme Laboratories, Inc., Quest Diagnostics, Inc., Tosoh Bioscience, Hologram Sciences, and Maccura Biotechnology Co.

Key Developments:

In April 2021, Hologram Sciences (US) launched its direct-to-consumer services. Its app includes access to live coaching from registered dietitians. Consumers choosing its subscription option will receive a free two-pack vitamin D test kit to test vitamin D levels.

In May 2020, Abbott announced the availability of ID NOW in the U.S., a point-of-care quick test that provides results in minutes rather than taking days or weeks to deliver the test results.

In March 2020, Thermo Fisher Scientific Inc. announced the availability of Cascadion SM Clinical Analyzer for Cascadion SM 25-hydroxy vitamin D assay in the U.S. with an aim to expand its brand presence.

Test Types Covered:

• 24,25-Dihydroxy Vitamin D Testing
• 1,25-Dihydroxy Vitamin D Testing
• 25-Hydroxy Vitamin D Testing

Products Covered:

• Reagents
• Kits
• Instruments

Techniques Covered:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay
• Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS)
• High Performance Liquid Chromatography (HPLC)
• Chemiluminescence ImmunoAssay (CLIA)

Indications Covered:

• Rickets
• Malabsorption
• Osteoporosis
• Thyroid Disorders
• Vitamin D Deficiency

Vitamin Types Covered:

• Vitamin D2
• Vitamin D3

Types Covered:

• Point-of-Care (POC)
• In-home Testing

Patients Covered:

• Pediatric
• Adults
• Child
• Geriatrics
• Pregnant Women

Sales Channels Covered:

• Distributor
• Direct Sales

Applications Covered:

• Research Testing
• Clinical Testing

End Users Covered:

• Hospitals & Physician Clinics
• Standalone Clinical Laboratories
• Home Care Settings
• Diagnostic Laboratories
• Pharmaceuticals
• Animal Feed and Pet Food
• Personal Care
• Functional Food & Beverages
• Private Laboratories

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances